Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Canadian producer enters German market through partnership

Avant Brands and IM Cannabis announced the signing of an International Trademark Licensing Agreement granting IMC's German subsidiary, Adjupharm GmbH, the exclusive right to launch Avant's flagship brand, BLK MKT brand in the German cannabis market. The Licensing Agreement constitutes a significant expansion of the relationship between the two cannabis companies.

Norton Singhavon, Founder and CEO of Avant Brands, commented: "This agreement signifies a significant milestone in our longstanding partnership with IMC. As Avant's first client within our international sales channel, partnering with IMC is a strategic move; it not only bolsters our position as a global leader in the ultra-premium cannabis sector, it also amplifies the reach of our flagship brand, BLK MKT, on the global stage. We are thrilled to embark on this next phase of collaboration, leveraging our collective expertise driving innovation and excellence in the international cannabis market."

In accordance with the terms outlined in the Trademark License Agreement, Avant has granted Adjupharm the license to utilize its flagship BLK MKT cannabis brand for their cannabis products. These products will exclusively feature cannabis cultivated by Avant in Canada and exported to Germany. The collaboration between the two companies anticipates a positive outcome in the emerging German medical cannabis market, especially following the recent legalization by the government on April 1st, 2024 . This strategic partnership, timed with evolving German legislative changes, underscores a growing acknowledgment of cannabis' therapeutic advantages and signifies a progressive shift in drug policy within Germany. Avant and IMC are confident the integration of Avant's BLK MKT premium cannabis flower, alongside IMC's adept sales and marketing strategies, will resonate strongly with consumers, positioning the brand for success in Germany's burgeoning market.

Oren Shuster, CEO of IMC, commented: "By evolving our partnership with Avant, we continue to improve our supply chain and ability to provide ultra-premium, quality brand and product to the German medical cannabis market."

Richard Balla, CEO of Adjupharm additionally stated: "We believe that our collaboration with Avant will continue to accelerate the strong momentum we have established in the German medical cannabis market."

David Lynn, COO of Avant Brands, added: "We are very excited to be working with IMC's German team. We are confident that they will do an outstanding job launching the BLK MKT brand in Germany."

Avant's three largest cultivation facilities are certified with both ICANN-GAP (International Cannabis Certification Network - Good Agricultural Practices) and GACP (Good Agricultural and Collection Practices). With these certifications, Avant is not only positioned to meet the stringent regulatory requirements of domestic markets but also equipped to expand its reach into international markets with confidence.

For more information:
Avant Brands

Publication date: